Luca Ceriani (L Ceriani)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 14

Top Venues

Hematological oncology

Blood

Blood advances

Cancers

Oncology Institute of Souther Switzerland

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oncology Institute of Souther Switzerland

Switzerland

Deputy Head :: Nuclear medicine and PET/CT centre

Publications

Jakoba Johanna Eertink, Gerben J C Zwezerijnen, Martijn Heymans, Simone Pieplenbosch, Sanne Elisabeth Wiegers, Ulrich Dührsen, Andreas Huettmann, Lars Kurch, Christine Hanoun, Pieternella J Lugtenburg, Sally F Barrington, N George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sandor Czibor, Tamás Györke, Martine E D Chamuleau, Otto S Hoekstra, Henrica C W de Vet, Ronald Boellaard, Josée J M Zijlstra-Baalbergen
Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma. Blood (2023)
Anastasios Stathis, Ulrich Mey, Sämi Schär, Felicitas Hitz, Christiane Pott, Nicolas Mach, Fatime Krasniqi, Urban Novak, Christian Schmidt, Karin Hohloch, Dirk Lars Kienle, Dagmar Hess, Alden A Moccia, Michael Unterhalt, Katrin Eckhardt, Stefanie Hayoz, Gabriela Forestieri, Davide Rossi, Stefan Dirnhofer, Luca Ceriani, Giulio Sartori, Francesco Bertoni, Christian Buske, Emanuele Zucca, Wolfgang Hiddemann
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma. Blood advances 6 (13) (2022)
Adalgisa Condoluci, Lisa Milan, Gabriela Forestieri, Lodovico Terzi di Bergamo, Valeria Spina, Alessio Bruscaggin, Clara Deambrogi, Riccardo Moia, Marina Deodato, Gaby Fahrni, Roberta Mattarucchi, Michele Merli, Bernhard Gerber, Georg Stussi, Francesco Passamonti, Michael Gregor, Alessandra Tedeschi, Gianluca Gaidano, Davide Rossi, Luca Ceriani
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib. Hematological oncology (2022)
Sofia Genta, Guido Ghilardi, Luciano Cascione, Darius Juskevicius, Alexandar Tzankov, Sämi Schär, Lisa Milan, Maria Cristina Pirosa, Fabiana Esposito, Teresa Ruberto, Luca M Giovanella, Stefanie Hayoz, Christoph Mamot, Stefan Dirnhofer, Emanuele Zucca, Luca Ceriani
Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. Cancers 14 (4) (2022)
Luca Ceriani, Emanuele Zucca
D max : A simple and reliable PET/CT-derived new biomarker of lymphoma outcome? Hematological oncology (2022)
Luca Ceriani, Lisa Milan, Luciano Cascione, Giuseppe Gritti, Federico Dalmasso, Fabiana Esposito, Maria Cristina Pirosa, Sämi Schär, Andrea Bruno, Stephan Dirnhofer, Luca Giovanella, Stefanie Hayoz, Christoph Mamot, Alessandro Rambaldi, Stephane Chauvie, Emanuele Zucca
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis. Hematological oncology (2021)
Jakoba Johanna Eertink, C N Burggraaff, M W Heymans, U Dührsen, Andreas Huettmann, C Schmitz, S Müller, Pieternella J Lugtenburg, Sally F Barrington, N George Mikhaeel, R Carr, S Czibor, Tamás Györke, Luca Ceriani, Emanuele Zucca, Martin Hutchings, L Kostakoglu, A Loft, S Fanti, Sanne Elisabeth Wiegers, S Pieplenbosch, R Boellaard, O S Hoekstra, Josée J M Zijlstra-Baalbergen, Henrica C W de Vet
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients. Blood advances 5 (9) (2021)
Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, Lodovico Terzi di Bergamo, Martin Richard Faderl, Valeria Spina, Adalgisa Condoluci, Luisella Bonomini, Gabriela Forestieri, Ricardo Koch, Deborah Piffaretti, Katia Pini, Maria C Pirosa, Micol Giulia Cittone, Alberto J Arribas, Marco Lucioni, Guido Ghilardi, Wei Wu, Luca Arcaini, Maria Joao Baptista, Gabriela Bastidas, Sílvia Beà, Renzo Boldorini, Alessandro Broccoli, Marco Matteo Bühler, Vincenzo Canzonieri, Luciano Cascione, Luca Ceriani, Sergio B Cogliatti, Paolo Corradini, Enrico Derenzini, Liliana Devizzi, Sascha Dietrich, Angela Rita Elia, Fabio Facchetti, Gianluca Gaidano, Juan Fernando García, Bernhard Gerber, Paolo Ghia, Maria Gomes da Silva, Giuseppe Gritti, Anna Guidetti, Felicitas Hitz, Giorgio Ga Inghirami, Marco Ladetto, Armando López-Guillermo, Elisa Lucchini, Antonino Maiorana, Roberto Marasca, Estella Matutes, Véronique Meignin, Michele Merli, Alden A Moccia, Manuela Mollejo, Carlos Montalban, Urban Novak, David Graham Oscier, Francesco Passamonti, Francesco A Piazza, Stefano Pizzolitto, Alessandro Rambaldi, Elena Sabattini, Gilles Andre Salles, Elisa Santambrogio, Lydia Scarfo, Anastasios Stathis, Georg Stussi, Julia Turbiner Geyer, Gustavo Tapia, Corrado Tarella, Catherine Thieblemont, Thomas Tousseyn, Alessandra Tucci, Giorgio Vanini, Carlo Visco, Umberto Vitolo, Renata Walewska, Francesco Zaja, Thorsten Zenz, Pier Luigi Luigi Zinzani, Hossein Khiabanian, Arianna Calcinotto, Francesco Bertoni, Govind Bhagat, Elias Campo, Laurence de Leval, Stefan Dirnhofer, Stefano A Pileri, Miguel A Piris, Alexandra Traverse-Glehen, Alexandar Tzankov, Marco Paulli, Maurilio Ponzoni, Luca Mazzucchelli, Franco Cavalli, Emanuele Zucca, Davide Rossi
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma. Blood (2021)
Emanuele Zucca, Luciano Cascione, Teresa Ruberto, Davide Facchinelli, Sämi Schär, Stefanie Hayoz, Stefan Dirnhofer, Luca M Giovanella, Mario Bargetzi, Christoph Mamot, Luca Ceriani
Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B-cell lymphoma: post-hoc analysis from the SAKK38/07 clinical trial. Hematological oncology 38 (5) (2020)
Luca Ceriani, Lisa Milan, Peter W M Johnson, Maurizio Martelli, Stefano Presilla, Luca Giovanella, Emanuele Zucca
Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume. European journal of nuclear medicine and molecular imaging 46 (6) (2019)
Luca M Giovanella, Gaetano Paone, Teresa Ruberto, Luca Ceriani, Pierpaolo Trimboli
99mTc-Pertechnetate Scintigraphy Predicts Successful Postoperative Ablation in Differentiated Thyroid Carcinoma Patients Treated with Low Radioiodine Activities. Endocrinology and metabolism (Seoul, Korea) 34 (1) (2019)
Pierpaolo Trimboli, Gaetano Paone, Giorgio Treglia, Camilla Virili, Teresa Ruberto, Luca Ceriani, Arnoldo Piccardo, Luca M Giovanella
Fine-needle aspiration in all thyroid incidentalomas at 18 F-FDG PET/CT: Can EU-TIRADS revise the dogma? Clinical endocrinology 89 (5) (2018)
Luca Ceriani, Lisa Milan, Maurizio Martelli, Andrés J M Ferreri, Luciano Cascione, Pier Luigi Zinzani, Alice Di Rocco, Annarita Conconi, Anastasios Stathis, Franco Cavalli, Monica Bellei, Kelly Cozens, Elena Porro, Luca M Giovanella, Peter W Johnson, Emanuele Zucca
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma. Blood 132 (2) (2018)
Luca Ceriani, Maurizio Martelli, Annarita Conconi, Pier L Zinzani, Andrés J M Ferreri, Barbara Botto, Caterina Stelitano, Manuel Gotti, Maria G Cabras, Luigi Rigacci, Luca Giovanella, Emanuele Zucca, Peter W M Johnson
Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study. British journal of haematology 178 (4) (2017)

Luca Ceriani.css-eqlu8i{font-size:small;padding-left:4px;} (L Ceriani)

Publication Activity (10 Years)

Top Topics

Top Venues

Luca Ceriani (L Ceriani)